See more : Chigo Holding Limited (0449.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Medicine Man Technologies, Inc. (SHWZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medicine Man Technologies, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Harel Insurance Investments & Financial Services Ltd (HAHRF) Income Statement Analysis – Financial Results
- China Steel Structure Co., Ltd. (2013.TW) Income Statement Analysis – Financial Results
- Avianca Holdings S.A. (AVHOQ) Income Statement Analysis – Financial Results
- Ambipar Participações e Empreendimentos S.A. (AMBP3.SA) Income Statement Analysis – Financial Results
- LCC Infotech Limited (LCCINFOTEC.NS) Income Statement Analysis – Financial Results
Medicine Man Technologies, Inc. (SHWZ)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.schwazze.com
About Medicine Man Technologies, Inc.
Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. It operates through three segments: Retail, Wholesale, and Other. The company offers cannabis products that include loose flower, concentrates, edibles, pre-rolls, topicals, and other associated cannabis products; and vape cartridges and syringes. As of March 14, 2022, it owned and operated 23 retail cannabis dispensaries under the Star Buds, Smoking Gun Apothecary, Emerald Fields, and Drift banner names in Denver and Colorado; and 10 medical retail cannabis dispensaries under the R. Greenleaf banner in New Mexico. The company also provides licensing and consulting, facility design, and facility management services; and Three A Light publication. In addition, it manufactures, wholesales, and retails various plant nutrients for cannabis; and supplies hydroponics and indoor gardening supplies. The company was incorporated in 2014 and is headquartered in Denver, Colorado.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 172.45M | 159.38M | 108.42M | 24.00M | 10.62M | 7.92M | 3.53M | 631.46K | 835.78K | 251.89K |
| Cost of Revenue | 96.42M | 74.35M | 59.07M | 17.23M | 7.62M | 2.58M | 1.30M | 462.18K | 209.75K | 72.00K |
| Gross Profit | 76.02M | 85.03M | 49.35M | 6.77M | 3.00M | 5.35M | 2.23M | 169.27K | 626.03K | 179.89K |
| Gross Profit Ratio | 44.09% | 53.35% | 45.52% | 28.23% | 28.27% | 67.47% | 63.10% | 26.81% | 74.90% | 71.42% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 70.93M | 64.16M | 38.94M | 29.68M | 16.47M | 4.40M | 7.13M | 1.01M | 519.88K | 193.15K |
| Selling & Marketing | 0.00 | -34.77M | 0.00 | 0.00 | 0.00 | 291.71K | 183.78K | 311.52K | 16.00K | 15.50K |
| SG&A | 70.93M | 64.16M | 38.94M | 29.68M | 16.47M | 4.69M | 7.31M | 1.32M | 535.88K | 208.64K |
| Other Expenses | 1.80M | 24.14K | 22.33M | 32.62K | 11.99M | 1.37M | -70.04K | 165.02K | 0.00 | 0.00 |
| Operating Expenses | 72.73M | 64.16M | 38.94M | 29.68M | 16.47M | 4.69M | 7.31M | 1.32M | 535.88K | 208.64K |
| Cost & Expenses | 169.16M | 138.51M | 98.01M | 46.90M | 24.08M | 7.27M | 8.62M | 1.78M | 745.62K | 280.64K |
| Interest Income | 0.00 | 30.14M | 7.01M | 41.46K | 31.91K | 30.00K | 30.00K | 14.02K | 8.07K | 3.12K |
| Interest Expense | 32.07M | 30.14M | 7.01M | 41.46K | 192.11K | 0.00 | 86.02K | 125.16K | 0.00 | 1.18K |
| Depreciation & Amortization | 20.93M | 11.55M | 8.58M | 476.59K | 61.71K | 81.96K | 63.74K | 17.37K | 6.62K | 561.00 |
| EBITDA | 37.52M | 38.12M | 3.47M | -19.80M | -13.55M | 1.61M | -5.23M | -1.42M | 96.77K | -30.40K |
| EBITDA Ratio | 21.76% | 20.02% | 3.20% | -104.26% | -89.16% | 9.64% | -143.42% | -177.48% | 11.58% | -9.95% |
| Operating Income | 3.29M | 20.89M | -5.11M | -22.90M | -13.46M | 2.17M | -5.24M | -1.15M | 90.15K | -28.75K |
| Operating Income Ratio | 1.91% | 13.11% | -4.71% | -95.43% | -126.80% | 27.39% | -148.34% | -182.45% | 10.79% | -11.41% |
| Total Other Income/Expenses | -18.10M | -16.42M | 8.51M | 2.59M | -476.76K | -638.50K | -145.22K | -312.18K | 8.07K | 1.94K |
| Income Before Tax | -14.81M | -3.57M | 18.92M | -20.32M | -17.56M | 1.53M | -5.38M | -1.46M | 98.22K | -26.81K |
| Income Before Tax Ratio | -8.59% | -2.24% | 17.45% | -84.65% | -165.36% | 19.33% | -152.46% | -231.89% | 11.75% | -10.64% |
| Income Tax Expense | 19.74M | 14.90M | 4.40M | -899.11K | -582.93K | 582.93K | 15.98K | 125.16K | 12.48K | 3.14K |
| Net Income | -34.55M | -18.47M | 14.52M | -19.42M | -16.98M | 948.92K | -5.38M | -1.46M | 85.75K | -29.95K |
| Net Income Ratio | -20.03% | -11.59% | 13.39% | -80.90% | -159.87% | 11.97% | -152.46% | -231.89% | 10.26% | -11.89% |
| EPS | -0.26 | -0.34 | 0.17 | -0.47 | -0.50 | 0.03 | -0.23 | -0.14 | 0.01 | 0.00 |
| EPS Diluted | -0.26 | -0.34 | -0.06 | -0.47 | -0.50 | 0.03 | -0.23 | -0.14 | 0.01 | 0.00 |
| Weighted Avg Shares Out | 64.54M | 53.64M | 43.34M | 41.22M | 33.74M | 27.77M | 22.99M | 10.23M | 9.91M | 9.84M |
| Weighted Avg Shares Out (Dil) | 64.54M | 53.64M | 101.37M | 41.22M | 33.74M | 27.77M | 22.99M | 10.23M | 9.91M | 9.97M |
Medicine Man Technologies, Inc. (SHWZ) Q4 2023 Earnings Call Transcript
Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results
Schwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 p.m. ET
From Seed to Profit: The Top Cannabis Penny Stocks to Watch
Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer
Medicine Man Technologies, Inc. (SHWZ) Q3 2023 Earnings Call Transcript
Schwazze Announces Third Quarter 2023 Financial Results
Schwazze Sets Third Quarter 2023 Conference Call for November 14, 2023 at 5:00 p.m. ET
Schwazze Announces Launch of Standing Akimbo Hotspot, a New Store Within A Store Concept in Fort Collins
Marijuana Penny Stocks for September Investment Watchlist
Source: https://incomestatements.info
Category: Stock Reports